Senhwa Biosciences, Inc. (TPEX:6492)
Taiwan · Delayed Price · Currency is TWD 45.50
+0.30 (0.66%)
Oct 31, 2025, 2:31 PM CST
Senhwa Biosciences Market Cap
Senhwa Biosciences has a market cap or net worth of 4.06 billion as of October 31, 2025. Its market cap has decreased by -13.17% in one year.
Market Cap
4.06B
Enterprise Value
3.19B
Revenue
1.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
45.50
Market Cap Chart
Since December 4, 2014, Senhwa Biosciences's market cap has decreased from 6.81B to 4.06B, a decrease of -40.42%. That is a compound annual growth rate of -4.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 4.06B | 4.60% |
| Dec 31, 2024 | 3.88B | -14.54% |
| Dec 29, 2023 | 4.54B | -11.69% |
| Dec 30, 2022 | 5.14B | -44.90% |
| Dec 30, 2021 | 9.33B | -53.73% |
| Dec 31, 2020 | 20.16B | 319.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |